Delivery Order SPE2DB24D1107-SPE2DB25FZEK5

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.36, is a delivery order for 4,567,154,351 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of February 5, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,378.24, is for the delivery of 4,567,037,738 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The contract is a firm fixed-price Delivery Order with a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,283,081 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The firm-fixed-price delivery order, valued at $1,382.20, has a completion date of January 10, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,340.61 firm fixed price delivery order is for the supply of 4,566,479,417 units of Oseltamivir Phosphate 75 mg capsules, an antiviral medication. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2022. This delivery order falls under Amerisourcebergen's $999,999,999...
This federal contract award, valued at $1,272.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,646,936 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of October 31, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.63 Firm Fixed Price delivery order is for the supply of 4,567,218,387 units of the antiviral drug oseltamivir phosphate 75 mg capsules. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. This award is associated with a larger $999,999,999 Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,394,389 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 23, 2024 and a ceiling value of $3,630.81. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
The federal contract award is for the delivery of 4,563,327,071 units of the pharmaceutical product Oseltamivir Phosphate 75 mg Capsules. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,188.72 and an ultimate completion date of January 16, 2024. The contract is not designated with a set-aside and appears to be an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,173,154 units of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,390.66 and runs through February 6, 2025. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,198,891 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $3,189.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense responsible for providing medical supplies to military treatment facilities and other federal healthcare programs. The contract has no...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZEK5
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of 4,567,254,103 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $1,379.28 firm fixed-price delivery order contract has a completion date of February 13, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 5/14/25, 10:03 AM